New lung cancer combo aims to boost treatment completion
Disease control
Recruiting now
This study tests a new way to give radiation therapy for stage III lung cancer that cannot be removed by surgery. It combines a smaller, faster radiation field with standard chemotherapy and an immunotherapy drug called durvalumab. The goal is to see if this approach helps more p…
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC